Brace Pharma
Brace Pharma is a Maryland- based investment company specialized in investments in clinical-stage projects.
Business Model:
Revenue: $8.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Brace Pharma Information
Geographic Data
Address: 155 Gibbs St
City: Rockville
State: MD
Zip: 20850
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Brace Pharma Capital is a strategic investment company formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors. We invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options.
Contact Phone:
+12404037153
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2015 | Therabron | Series B | 6.8M |
| 8/2020 | ReViral | Series C | 0 |
| 6/2016 | F2G | Series E | 60M |
| 10/2018 | Avidity Biosciences | Series B | 0 |
| 6/2014 | Tyrogenex | Series D | 15M |
| 11/2015 | Viridian Therapeutics | Series C | 0 |
| 5/2020 | HotSpot Therapeutics | Series B | 65M |
| 6/2018 | Precision BioSciences | Series B | 0 |
| 8/2018 | ReViral | Series B | 0 |
| 9/2015 | ReViral | Series A | 21M |
| 3/2017 | Antiva Biosciences | Series C | 22M |
| 12/2014 | Therabron | Series B | 11.1M |
| 8/2020 | F2G | Private Equity Round | 0 |
| 2/2018 | Avrobio | Series B | 60M |
| 7/2018 | Antiva Biosciences | Series C | 15M |
| 2/2021 | Pipeline Therapeutics | Series C | 0 |
| 12/2015 | Navitor Pharmaceuticals | Series B | 33M |
| 12/2019 | Pipeline Therapeutics | Series B | 0 |
| 11/2021 | Antiva Biosciences | Series D | 0 |
| 7/2021 | Turnstone Biologics | Series D | 0 |
| 1/2016 | Zymeworks | Series A | 0 |
| 11/2019 | Avidity Biosciences | Series C | 0 |
| 11/2021 | Antiva Biosciences | Series D | 0 |
| 7/2021 | Turnstone Biologics | Series D | 0 |
| 2/2021 | Pipeline Therapeutics | Series C | 0 |
| 8/2020 | ReViral | Series C | 0 |
| 8/2020 | F2G | Private Equity Round | 0 |
| 5/2020 | HotSpot Therapeutics | Series B | 0 |
| 12/2019 | Pipeline Therapeutics | Series B | 0 |
| 11/2019 | Avidity Biosciences | Series C | 0 |
| 10/2018 | Avidity Biosciences | Series B | 0 |
| 8/2018 | ReViral | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
